240 mg/5 ml, oral suspension
Paracetamolum
for infants and children
important information for the patient.
This medicine should always be used exactly as described in this patient leaflet or as directed by
your doctor or pharmacist.
Paracetamol Hasco Forte, oral suspension is an antipyretic and analgesic medicine intended for use in infants and children. When used in recommended doses, it is well tolerated.
Fever and pains of various origins (e.g. after surgical procedures, teething pains, mild to moderate headaches) and symptoms accompanying the body's reaction to vaccination (pain, fever, local reaction).
In addition, the medicine is used in infants from 0 to 3 months of age (with a body weight of up to 4 kg) for the symptomatic treatment of fever lasting no longer than 3 days and pain of mild to moderate severity.
If after 3 days there is no improvement or the patient feels worse, they should consult a doctor.
Before starting to use Paracetamol Hasco Forte, you should discuss it with your doctor or pharmacist.
Do not use with other medicines containing paracetamol due to the risk of overdose. In case of overdose, consult a doctor immediately, even if the patient feels well.
Without a doctor's recommendation, do not use for more than 3 days. Do not use doses larger than recommended.
The medicine should be used with caution in patients with liver and kidney failure. There is a special risk of liver damage in malnourished individuals. Caution should be exercised when using in patients with reduced glutathione levels (such as in sepsis).
Using paracetamol may increase the risk of metabolic acidosis. Caution should be exercised when using paracetamol in patients with glucose-6-phosphate dehydrogenase deficiency and methemoglobin reductase deficiency.
During the use of Paracetamol Hasco Forte, the doctor should be informed immediately if the patient has severe diseases, including severe kidney dysfunction or sepsis (when bacteria and their toxins circulate in the blood, leading to organ damage) or malnutrition, chronic alcoholism, or if the patient is also taking flucloxacillin (an antibiotic). In these situations, patients have been reported to develop a severe disease called metabolic acidosis (a blood and body fluid disorder), when they used paracetamol in regular doses for a longer period or when they took paracetamol with flucloxacillin. Symptoms of metabolic acidosis may include: severe breathing difficulties, including rapid deep breathing, drowsiness, feeling of nausea (nausea) and vomiting.
In patients with asthma, hypersensitivity to salicylates (e.g. acetylsalicylic acid) may occur with paracetamol.
Available study results indicate that paracetamol administration may be a risk factor for the development of asthma and allergic diseases in children.
You should tell your doctor or pharmacist about all medicines the patient is currently taking or has recently taken, as well as any medicines the patient plans to take.
The medicine should not be taken with centrally acting analgesics or with alcohol, as it enhances their effect. In the case of concurrent use: barbiturates, antiepileptic drugs (including glutethimide, phenobarbital, phenytoin, carbamazepine), rifampicin, the harmful effect of paracetamol on the liver is increased. Paracetamol increases the toxicity of chloramphenicol.
Prolonged use of paracetamol in high doses enhances the effect of oral anticoagulant medicines from the coumarin group.
Concomitant use of paracetamol with non-steroidal anti-inflammatory drugs (NSAIDs) increases the risk of kidney function disorders. Paracetamol used concomitantly with MAO inhibitors may cause a state of excitement and high temperature.
The absorption of paracetamol is accelerated by drugs that accelerate gastric emptying (e.g. metoclopramide, domperidone) and delayed by drugs that delay gastric emptying (e.g. cholestyramine).
Using paracetamol in combination with zidovudine may cause neutropenia. Salicylamide prolongs the elimination time of paracetamol.
Using paracetamol may be the cause of false results in some laboratory tests (e.g. blood glucose measurement).
You should inform your doctor or pharmacist if the patient is taking flucloxacillin (an antibiotic) due to the serious risk of blood and body fluid disorders (called metabolic acidosis), which must be urgently treated (see section 2).
While using Paracetamol Hasco Forte, you should not drink alcohol, as it may cause liver damage.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult a doctor or pharmacist before using this medicine.
Like other medicines, this medicine should be used during pregnancy and breastfeeding only if necessary.
The medicine has no effect on the ability to drive vehicles and operate machines.
This should be taken into account in patients with diabetes. If the patient has previously been diagnosed with intolerance to some sugars, they should consult a doctor before taking the medicine.
Sodium metabisulfite may rarely cause severe hypersensitivity reactions and bronchospasm.
Sodium benzoate may increase the risk of jaundice (yellowing of the skin and whites of the eyes) in newborns (up to 4 weeks of age).
Paracetamol Hasco Forte contains less than 1 mmol (23 mg) of sodium per 5 ml of suspension, which means the medicine is considered "sodium-free".
Before administering the medicinal product to a child under 4 weeks of age, you should consult a doctor or pharmacist, especially if the child is taking other medicinal products containing propylene glycol or alcohol.
This medicine should always be used exactly as described in this patient leaflet or as directed by your doctor or pharmacist. If you are unsure, you should consult a doctor or pharmacist.
The medicine is for oral use.
Before use, shake the bottle vigorously to obtain a uniform suspension.
Unless otherwise directed by a doctor, the average single dose of paracetamol is 10 mg to 15 mg per kilogram of body weight.
If necessary, the dose can be repeated, but not more often than every 4-6 hours, up to 4 times a day, i.e. a maximum of 60 mg/kilogram of body weight/day.
Age (child's body weight) | Recommended single dose | Maximum daily dose |
from 0 to 3 months of age (up to 4 kg) | 1.25 ml (60 mg) | 5 ml (240 mg) |
from 4 to 8 months of age (up to 7 kg) | 2 ml (96 mg) | 8 ml (384 mg) |
from 9 to 11 months of age (up to 8 kg) | 2.5 ml (120 mg) | 10 ml (480 mg) |
from 1 to 2 years of age (up to 10.5 kg) | 3.25 ml (156 mg) | 13 ml (624 mg) |
from 2 to 3 years of age (up to 13 kg) | 4 ml (192 mg) | 16 ml (768 mg) |
from 4 to 5 years of age (up to 18.5 kg) | 6 ml (288 mg) | 24 ml (1152 mg) |
from 6 to 8 years of age (up to 24 kg) | 7.5 ml (360 mg) | 30 ml (1440 mg) |
from 9 to 10 years of age (up to 32 kg) | 10 ml (480 mg) | 40 ml (1920 mg) |
from 11 to 12 years of age (up to 45.6 kg) | 14.25 ml (684 mg) | 57 ml (2736 mg) |
Without consulting a doctor, do not use for more than 3 days. Use in children under 2 years of age should be prescribed by a doctor. An oral syringe is attached to the packaging.
Instructions for dosing with an oral syringe:
There are no special instructions for use with food.
If you feel that the effect of Paracetamol Hasco Forte is too strong or too weak, you should consult a doctor .
In case of taking a higher dose of the medicine than recommended, you should immediately consult a doctor or pharmacist, even if the patient feels well.
Severe poisoning may occur in children after taking 200 mg of paracetamol/kg of body weight.
Accidental or intentional overdose of paracetamol may cause symptoms such as: nausea, vomiting, excessive sweating, drowsiness, and general weakness within a few or several hours. These symptoms may resolve the next day, despite the slow development of severe liver damage, manifested by a feeling of fullness in the upper abdomen, nausea, and jaundice.
Treatment of paracetamol poisoning must be carried out in a hospital, under intensive medical care. If it has been less than an hour since taking paracetamol, you should induce vomiting and administer activated charcoal.
Paracetamol Hasco Forte is used as needed, when symptoms occur. It should be taken according to the recommendations given in section 3. However, if a doctor recommends regular use of the medicine, you should not take a double dose to make up for a missed dose.
If you have any further doubts about using this medicine, you should consult a doctor or pharmacist .
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Rarely(in 1 to 10 patients out of 10,000):
allergic skin reactions: hives, rash, skin inflammation.
Very rarely(in less than 1 patient out of 10,000):
decreased platelet count (thrombocytopenia)
decreased white blood cell count (leukopenia, agranulocytosis)
nausea, vomiting, diarrhea
liver function disorders.
Frequency not known(cannot be estimated from the available data):
a serious disease that can cause acidification of the blood (so-called metabolic acidosis), in patients with severe disease taking paracetamol (see section 2).
Long-term use of the medicine or overdose may cause liver and kidney damage, as well as methemoglobinemia with symptoms of cyanosis (gray-blue skin discoloration).
There have been reports of very rare cases of severe skin reactions (acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis).
If you experience any side effects, including any side effects not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181 C, 02-222 Warsaw,
phone: 22 49 21 301, fax: 22 49 21 309,
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Store in a temperature below 25°C. The product should not be stored in an inverted position.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Shelf life after first opening: 12 months.
Medicines should not be disposed of via wastewater or household waste containers. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
A milky to light yellow suspension with a strawberry smell. The packaging contains 150 ml, 100 ml, or 85 ml of oral suspension.
A bottle made of orange glass type III with an HDPE cap, with a guarantee ring and a connector made of LDPE for an oral syringe, and an oral syringe made of LDPE/PS with a capacity of 5 ml, with a scale every 0.25 ml, in a cardboard box.
"PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK" S.A.
51-131 Wrocław, ul. Żmigrodzka 242 E
phone: 22 742 00 22
e-mail: informacjaoleku@hasco-lek.pl
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.